Harpoon Therapeutics: Custom Supplier Solutions by Thermo Fishner

We are excited to announce the collaboration between Harpoon Therapeutics and T&L Biotechnology Co., Ltd. to develop novel cancer therapeutics. Harpoon Therapeutics is a clinical-stage immunotherapy company developing a new class of T Cell engagers that harness the power of the body's immune system to treat patients suffering from cancer. T&L Biotechnology Co., Ltd. is a leading biotechnology company with expertise in antibody development and manufacturing, This partnership will leverage Harpoon's proprietary Tri-specific T cell Activating Construct (TriTAC) platform and T&L Biotechnology's cutting-edge antibody development and manufacturing capabilities to advance next-generation cancer therapies. By combining Harpoon's innovative technology with the manufacturing expertise of T&L Biotechnology, we aim to accelerate the development and commercialization of potential cancer treatments, Our shared goal is to develop therapies that can make a meaningful difference for patients with cancer, and we are confident that our collaboration will lead to the advancement of novel cancer therapeutics. We look forward to the potential impact that our joint efforts will have on the field of oncology